Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
Harvard University · Massachusetts General Hospital
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
570
total citations
- FWCI
- 33.47
- Percentile
- 100%
- References
- 38
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Denosumab
- Teriparatide
- Medicine
- Bone mineral
- Osteoporosis
- Bone remodeling
- Bone density
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.